Guangdong Jiaying Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Guangdong Jiaying Pharmaceutical Co Ltd cash flow reinvestment rate. Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a Cash Flow Reinvestment Rate of 0.13x as of December 2024, reinvesting CN¥5.65 Million (capex CN¥4.57 Million plus investments CN¥1.08 Million) from operating cash flow of CN¥43.63 Million. Explore 002198 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Cash flow reinvestment rate of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025. Historical reinvestment intensity for Guangdong Jiaying Pharmaceutical Co Ltd across 22 annual periods. Explore 002198 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Guangdong Jiaying Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2004–2025)
Guangdong Jiaying Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2004 to 2025. Year-by-year capital reinvestment analysis for Guangdong Jiaying Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Guangdong Jiaying Pharmaceutical Co Ltd (002198) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 15.57x | CN¥140.15 Million | CN¥9.00 Million | CN¥109.92 Million | ▲ +2067.8% |
| 2024 | 0.72x | CN¥43.70 Million | CN¥60.85 Million | CN¥38.70 Million | ▲ +738.6% |
| 2023 | 0.09x | CN¥8.43 Million | CN¥98.45 Million | CN¥5.06 Million | ▼ -95.7% |
| 2022 | 1.98x | CN¥53.77 Million | CN¥27.15 Million | CN¥2.74 Million | ▲ +194.4% |
| 2021 | 0.67x | CN¥34.84 Million | CN¥51.80 Million | CN¥2.34 Million | ▲ +115.9% |
| 2020 | 0.31x | CN¥30.18 Million | CN¥96.87 Million | CN¥11.68 Million | ▼ -96.2% |
| 2019 | 8.11x | CN¥105.13 Million | CN¥12.96 Million | CN¥18.82 Million | ▲ +428.7% |
| 2018 | 1.53x | CN¥95.26 Million | CN¥62.10 Million | CN¥8.95 Million | ▲ +107.1% |
| 2017 | 0.74x | CN¥22.69 Million | CN¥30.63 Million | CN¥18.44 Million | ▲ +171.7% |
| 2016 | 0.27x | CN¥14.48 Million | CN¥53.13 Million | CN¥11.98 Million | ▼ -72.8% |
| 2015 | 1.00x | CN¥42.42 Million | CN¥42.31 Million | CN¥33.42 Million | ▲ +4.9% |
| 2014 | 0.96x | CN¥98.74 Million | CN¥103.36 Million | CN¥98.74 Million | ▲ +113.3% |
| 2013 | 0.45x | CN¥8.72 Million | CN¥19.46 Million | CN¥8.72 Million | ▼ -64.1% |
| 2012 | 1.25x | CN¥6.58 Million | CN¥5.27 Million | CN¥6.58 Million | ▼ -90.9% |
| 2011 | 13.78x | CN¥10.77 Million | CN¥781.89K | CN¥10.77 Million | ▲ +661.8% |
| 2010 | 1.81x | CN¥35.62 Million | CN¥19.70 Million | CN¥35.62 Million | ▼ -34.2% |
| 2009 | 2.75x | CN¥76.95 Million | CN¥27.98 Million | CN¥76.95 Million | ▲ +1.4% |
| 2008 | 2.71x | CN¥29.05 Million | CN¥10.71 Million | CN¥29.05 Million | ▲ +473.6% |
| 2007 | 0.47x | CN¥8.68 Million | CN¥18.35 Million | CN¥8.68 Million | ▼ -3.7% |
| 2006 | 0.49x | CN¥12.95 Million | CN¥26.37 Million | CN¥12.95 Million | ▲ +42.1% |
| 2005 | 0.35x | CN¥6.09 Million | CN¥17.63 Million | CN¥6.09 Million | ▼ -83.2% |
| 2004 | 2.05x | CN¥18.04 Million | CN¥8.78 Million | CN¥18.04 Million | — |